Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose cell-cell adhesion and gain migratory and invasive properties, has a pivotal role in metastasis. For...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular medicine reports 2015-12, Vol.12 (6), p.8003-8009
Hauptverfasser: OU-YANG, LEI, XIAO, SHENG-JUN, LIU, PENG, YI, SHI-JANG, ZHANG, XIAO-LING, OU-YANG, SHI, TAN, SHENG-KUI, LEI, XUN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8009
container_issue 6
container_start_page 8003
container_title Molecular medicine reports
container_volume 12
creator OU-YANG, LEI
XIAO, SHENG-JUN
LIU, PENG
YI, SHI-JANG
ZHANG, XIAO-LING
OU-YANG, SHI
TAN, SHENG-KUI
LEI, XUN
description Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose cell-cell adhesion and gain migratory and invasive properties, has a pivotal role in metastasis. Forkhead box C1 (FoxC1), a member of the forkhead family of transcription factors, induces EMT and has a critical role in metastasis of multiple human cancers. However, the role of FoxC1 in the progression of NPC has remained elusive. The present study revealed that the expression of FoxC1 was markedly elevated in NPC tissues compared with that in chronically inflamed nasopharyngeal tissues and was closely correlated with vimentin, fibronectin and N-cadherin expression as indicated by immunohisto-chemical assays. In addition, high FoxC1 expression was positively associated with lymph node metastasis, distant metastasis and an advanced clinical stage in patients with NPC. Furthermore, FoxC1 expression was high in NPC cell lines while being low in an immortalized normal nasopharyngeal epithelial cell line. In vitro, knockdown of FoxC1 in the CNE2 human NPC cell line by small interfering RNA downregulated vimentin, fibronectin and N-cadherin expression and reduced the migratory and invasive capacity of CNE2 cells. In conclusion, the present study indicated that FoxC1 has a pivotal role in EMT through the upregulation of vimentin, fibronectin and N-cadherin expression. Thus, FoxC1 may be a potential therapeutic target in NPC.
doi_str_mv 10.3892/mmr.2015.4427
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4758279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A439109692</galeid><sourcerecordid>A439109692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-52211a392905ad06f1f46c454b8cc42acf8b29fd648cc7ed82402575a3dc55923</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEoqVw5IoscYBLFn8nviBVKwpIlbjA2Zp1nI1LYgfbqaj48zjsslCEfPDHPPN6xn6r6jnBG9Yq-maa4oZiIjac0-ZBdU4aRWqGMX94XFOlmrPqSUo3GEtBhXpcnVHJJaFSnVc_rkL8Oljo0C58R1uCnO8WYxOys8uDHR2M9WST9Wa4m2BEOYJPLrvgEfgOuYQAzSFbn90aHWyE2S7ZGZQh7m0ueshDCvMA8c7vbYEMRON8mOBp9aiHMdlnx_mi-nL17vP2Q3396f3H7eV1bUSLcy0oJQSYogoL6LDsSc-l4YLvWmM4BdO3O6r6TvKyb2zXUo6paASwzgihKLuo3h5052U32c6UYiOMeo5uKkXpAE7fj3g36H241bwRLW1UEXh9FIjh22JT1pNLxo4jeBuWpEnDBGO8kAV9-Q96E5boS3uaKEZ5Q4iUf6g9jFY734dyr1lF9SVnimAlf9W9-Q9VRmcnZ4K3vSvn9xLqQ4KJIaVo-1OPBOvVLbq4Ra9u0atbCv_i74c50b_tUYBXByDN5bddF9KJKUo1oTWWdYsxYz8BqyPJAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932471166</pqid></control><display><type>article</type><title>Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>OU-YANG, LEI ; XIAO, SHENG-JUN ; LIU, PENG ; YI, SHI-JANG ; ZHANG, XIAO-LING ; OU-YANG, SHI ; TAN, SHENG-KUI ; LEI, XUN</creator><creatorcontrib>OU-YANG, LEI ; XIAO, SHENG-JUN ; LIU, PENG ; YI, SHI-JANG ; ZHANG, XIAO-LING ; OU-YANG, SHI ; TAN, SHENG-KUI ; LEI, XUN</creatorcontrib><description>Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose cell-cell adhesion and gain migratory and invasive properties, has a pivotal role in metastasis. Forkhead box C1 (FoxC1), a member of the forkhead family of transcription factors, induces EMT and has a critical role in metastasis of multiple human cancers. However, the role of FoxC1 in the progression of NPC has remained elusive. The present study revealed that the expression of FoxC1 was markedly elevated in NPC tissues compared with that in chronically inflamed nasopharyngeal tissues and was closely correlated with vimentin, fibronectin and N-cadherin expression as indicated by immunohisto-chemical assays. In addition, high FoxC1 expression was positively associated with lymph node metastasis, distant metastasis and an advanced clinical stage in patients with NPC. Furthermore, FoxC1 expression was high in NPC cell lines while being low in an immortalized normal nasopharyngeal epithelial cell line. In vitro, knockdown of FoxC1 in the CNE2 human NPC cell line by small interfering RNA downregulated vimentin, fibronectin and N-cadherin expression and reduced the migratory and invasive capacity of CNE2 cells. In conclusion, the present study indicated that FoxC1 has a pivotal role in EMT through the upregulation of vimentin, fibronectin and N-cadherin expression. Thus, FoxC1 may be a potential therapeutic target in NPC.</description><identifier>ISSN: 1791-2997</identifier><identifier>EISSN: 1791-3004</identifier><identifier>DOI: 10.3892/mmr.2015.4427</identifier><identifier>PMID: 26461269</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Adult ; Biotechnology ; Breast cancer ; Cadherins ; Cadherins - metabolism ; Carcinoma ; Care and treatment ; Cell adhesion ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cell migration ; Cell Movement ; Cervix ; Classification ; Epithelial cells ; Epithelial-Mesenchymal Transition ; epithelial-mesenchymal transition nasopharyngeal carcinoma ; Extracellular matrix ; Female ; Fibronectin ; Fibronectins - metabolism ; forkhead box C1 ; Forkhead protein ; Forkhead Transcription Factors - antagonists &amp; inhibitors ; Forkhead Transcription Factors - genetics ; Forkhead Transcription Factors - metabolism ; Gene Expression Regulation, Neoplastic ; Genes ; Genetic aspects ; Humans ; Immunohistochemistry ; Inflammation ; Invasiveness ; Liver cancer ; Lung cancer ; Lymph nodes ; Lymphatic Metastasis ; Male ; Malignancy ; Mesenchyme ; Metastases ; Metastasis ; Middle Aged ; N-Cadherin ; Nasopharyngeal cancer ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms - metabolism ; Nasopharyngeal Neoplasms - pathology ; Physiological aspects ; RNA Interference ; RNA, Small Interfering - metabolism ; siRNA ; Studies ; Throat cancer ; Transcription factors ; Vimentin ; Vimentin - metabolism</subject><ispartof>Molecular medicine reports, 2015-12, Vol.12 (6), p.8003-8009</ispartof><rights>Copyright: © Ou-Yang et al.</rights><rights>COPYRIGHT 2015 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2015</rights><rights>Copyright: © Ou-Yang et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-52211a392905ad06f1f46c454b8cc42acf8b29fd648cc7ed82402575a3dc55923</citedby><cites>FETCH-LOGICAL-c580t-52211a392905ad06f1f46c454b8cc42acf8b29fd648cc7ed82402575a3dc55923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,5572,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26461269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OU-YANG, LEI</creatorcontrib><creatorcontrib>XIAO, SHENG-JUN</creatorcontrib><creatorcontrib>LIU, PENG</creatorcontrib><creatorcontrib>YI, SHI-JANG</creatorcontrib><creatorcontrib>ZHANG, XIAO-LING</creatorcontrib><creatorcontrib>OU-YANG, SHI</creatorcontrib><creatorcontrib>TAN, SHENG-KUI</creatorcontrib><creatorcontrib>LEI, XUN</creatorcontrib><title>Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma</title><title>Molecular medicine reports</title><addtitle>Mol Med Rep</addtitle><description>Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose cell-cell adhesion and gain migratory and invasive properties, has a pivotal role in metastasis. Forkhead box C1 (FoxC1), a member of the forkhead family of transcription factors, induces EMT and has a critical role in metastasis of multiple human cancers. However, the role of FoxC1 in the progression of NPC has remained elusive. The present study revealed that the expression of FoxC1 was markedly elevated in NPC tissues compared with that in chronically inflamed nasopharyngeal tissues and was closely correlated with vimentin, fibronectin and N-cadherin expression as indicated by immunohisto-chemical assays. In addition, high FoxC1 expression was positively associated with lymph node metastasis, distant metastasis and an advanced clinical stage in patients with NPC. Furthermore, FoxC1 expression was high in NPC cell lines while being low in an immortalized normal nasopharyngeal epithelial cell line. In vitro, knockdown of FoxC1 in the CNE2 human NPC cell line by small interfering RNA downregulated vimentin, fibronectin and N-cadherin expression and reduced the migratory and invasive capacity of CNE2 cells. In conclusion, the present study indicated that FoxC1 has a pivotal role in EMT through the upregulation of vimentin, fibronectin and N-cadherin expression. Thus, FoxC1 may be a potential therapeutic target in NPC.</description><subject>Adult</subject><subject>Biotechnology</subject><subject>Breast cancer</subject><subject>Cadherins</subject><subject>Cadherins - metabolism</subject><subject>Carcinoma</subject><subject>Care and treatment</subject><subject>Cell adhesion</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement</subject><subject>Cervix</subject><subject>Classification</subject><subject>Epithelial cells</subject><subject>Epithelial-Mesenchymal Transition</subject><subject>epithelial-mesenchymal transition nasopharyngeal carcinoma</subject><subject>Extracellular matrix</subject><subject>Female</subject><subject>Fibronectin</subject><subject>Fibronectins - metabolism</subject><subject>forkhead box C1</subject><subject>Forkhead protein</subject><subject>Forkhead Transcription Factors - antagonists &amp; inhibitors</subject><subject>Forkhead Transcription Factors - genetics</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Inflammation</subject><subject>Invasiveness</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Lymph nodes</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Malignancy</subject><subject>Mesenchyme</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>N-Cadherin</subject><subject>Nasopharyngeal cancer</subject><subject>Nasopharyngeal Carcinoma</subject><subject>Nasopharyngeal Neoplasms - metabolism</subject><subject>Nasopharyngeal Neoplasms - pathology</subject><subject>Physiological aspects</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering - metabolism</subject><subject>siRNA</subject><subject>Studies</subject><subject>Throat cancer</subject><subject>Transcription factors</subject><subject>Vimentin</subject><subject>Vimentin - metabolism</subject><issn>1791-2997</issn><issn>1791-3004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkk1v1DAQhiMEoqVw5IoscYBLFn8nviBVKwpIlbjA2Zp1nI1LYgfbqaj48zjsslCEfPDHPPN6xn6r6jnBG9Yq-maa4oZiIjac0-ZBdU4aRWqGMX94XFOlmrPqSUo3GEtBhXpcnVHJJaFSnVc_rkL8Oljo0C58R1uCnO8WYxOys8uDHR2M9WST9Wa4m2BEOYJPLrvgEfgOuYQAzSFbn90aHWyE2S7ZGZQh7m0ueshDCvMA8c7vbYEMRON8mOBp9aiHMdlnx_mi-nL17vP2Q3396f3H7eV1bUSLcy0oJQSYogoL6LDsSc-l4YLvWmM4BdO3O6r6TvKyb2zXUo6paASwzgihKLuo3h5052U32c6UYiOMeo5uKkXpAE7fj3g36H241bwRLW1UEXh9FIjh22JT1pNLxo4jeBuWpEnDBGO8kAV9-Q96E5boS3uaKEZ5Q4iUf6g9jFY734dyr1lF9SVnimAlf9W9-Q9VRmcnZ4K3vSvn9xLqQ4KJIaVo-1OPBOvVLbq4Ra9u0atbCv_i74c50b_tUYBXByDN5bddF9KJKUo1oTWWdYsxYz8BqyPJAw</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>OU-YANG, LEI</creator><creator>XIAO, SHENG-JUN</creator><creator>LIU, PENG</creator><creator>YI, SHI-JANG</creator><creator>ZHANG, XIAO-LING</creator><creator>OU-YANG, SHI</creator><creator>TAN, SHENG-KUI</creator><creator>LEI, XUN</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151201</creationdate><title>Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma</title><author>OU-YANG, LEI ; XIAO, SHENG-JUN ; LIU, PENG ; YI, SHI-JANG ; ZHANG, XIAO-LING ; OU-YANG, SHI ; TAN, SHENG-KUI ; LEI, XUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-52211a392905ad06f1f46c454b8cc42acf8b29fd648cc7ed82402575a3dc55923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Biotechnology</topic><topic>Breast cancer</topic><topic>Cadherins</topic><topic>Cadherins - metabolism</topic><topic>Carcinoma</topic><topic>Care and treatment</topic><topic>Cell adhesion</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement</topic><topic>Cervix</topic><topic>Classification</topic><topic>Epithelial cells</topic><topic>Epithelial-Mesenchymal Transition</topic><topic>epithelial-mesenchymal transition nasopharyngeal carcinoma</topic><topic>Extracellular matrix</topic><topic>Female</topic><topic>Fibronectin</topic><topic>Fibronectins - metabolism</topic><topic>forkhead box C1</topic><topic>Forkhead protein</topic><topic>Forkhead Transcription Factors - antagonists &amp; inhibitors</topic><topic>Forkhead Transcription Factors - genetics</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Inflammation</topic><topic>Invasiveness</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Lymph nodes</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Malignancy</topic><topic>Mesenchyme</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>N-Cadherin</topic><topic>Nasopharyngeal cancer</topic><topic>Nasopharyngeal Carcinoma</topic><topic>Nasopharyngeal Neoplasms - metabolism</topic><topic>Nasopharyngeal Neoplasms - pathology</topic><topic>Physiological aspects</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering - metabolism</topic><topic>siRNA</topic><topic>Studies</topic><topic>Throat cancer</topic><topic>Transcription factors</topic><topic>Vimentin</topic><topic>Vimentin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OU-YANG, LEI</creatorcontrib><creatorcontrib>XIAO, SHENG-JUN</creatorcontrib><creatorcontrib>LIU, PENG</creatorcontrib><creatorcontrib>YI, SHI-JANG</creatorcontrib><creatorcontrib>ZHANG, XIAO-LING</creatorcontrib><creatorcontrib>OU-YANG, SHI</creatorcontrib><creatorcontrib>TAN, SHENG-KUI</creatorcontrib><creatorcontrib>LEI, XUN</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular medicine reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OU-YANG, LEI</au><au>XIAO, SHENG-JUN</au><au>LIU, PENG</au><au>YI, SHI-JANG</au><au>ZHANG, XIAO-LING</au><au>OU-YANG, SHI</au><au>TAN, SHENG-KUI</au><au>LEI, XUN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma</atitle><jtitle>Molecular medicine reports</jtitle><addtitle>Mol Med Rep</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>12</volume><issue>6</issue><spage>8003</spage><epage>8009</epage><pages>8003-8009</pages><issn>1791-2997</issn><eissn>1791-3004</eissn><abstract>Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose cell-cell adhesion and gain migratory and invasive properties, has a pivotal role in metastasis. Forkhead box C1 (FoxC1), a member of the forkhead family of transcription factors, induces EMT and has a critical role in metastasis of multiple human cancers. However, the role of FoxC1 in the progression of NPC has remained elusive. The present study revealed that the expression of FoxC1 was markedly elevated in NPC tissues compared with that in chronically inflamed nasopharyngeal tissues and was closely correlated with vimentin, fibronectin and N-cadherin expression as indicated by immunohisto-chemical assays. In addition, high FoxC1 expression was positively associated with lymph node metastasis, distant metastasis and an advanced clinical stage in patients with NPC. Furthermore, FoxC1 expression was high in NPC cell lines while being low in an immortalized normal nasopharyngeal epithelial cell line. In vitro, knockdown of FoxC1 in the CNE2 human NPC cell line by small interfering RNA downregulated vimentin, fibronectin and N-cadherin expression and reduced the migratory and invasive capacity of CNE2 cells. In conclusion, the present study indicated that FoxC1 has a pivotal role in EMT through the upregulation of vimentin, fibronectin and N-cadherin expression. Thus, FoxC1 may be a potential therapeutic target in NPC.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>26461269</pmid><doi>10.3892/mmr.2015.4427</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1791-2997
ispartof Molecular medicine reports, 2015-12, Vol.12 (6), p.8003-8009
issn 1791-2997
1791-3004
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4758279
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Biotechnology
Breast cancer
Cadherins
Cadherins - metabolism
Carcinoma
Care and treatment
Cell adhesion
Cell adhesion & migration
Cell Line, Tumor
Cell migration
Cell Movement
Cervix
Classification
Epithelial cells
Epithelial-Mesenchymal Transition
epithelial-mesenchymal transition nasopharyngeal carcinoma
Extracellular matrix
Female
Fibronectin
Fibronectins - metabolism
forkhead box C1
Forkhead protein
Forkhead Transcription Factors - antagonists & inhibitors
Forkhead Transcription Factors - genetics
Forkhead Transcription Factors - metabolism
Gene Expression Regulation, Neoplastic
Genes
Genetic aspects
Humans
Immunohistochemistry
Inflammation
Invasiveness
Liver cancer
Lung cancer
Lymph nodes
Lymphatic Metastasis
Male
Malignancy
Mesenchyme
Metastases
Metastasis
Middle Aged
N-Cadherin
Nasopharyngeal cancer
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms - metabolism
Nasopharyngeal Neoplasms - pathology
Physiological aspects
RNA Interference
RNA, Small Interfering - metabolism
siRNA
Studies
Throat cancer
Transcription factors
Vimentin
Vimentin - metabolism
title Forkhead box C1 induces epithelial-mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A05%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Forkhead%20box%20C1%20induces%20epithelial-mesenchymal%20transition%20and%20is%20a%20potential%20therapeutic%20target%20in%20nasopharyngeal%20carcinoma&rft.jtitle=Molecular%20medicine%20reports&rft.au=OU-YANG,%20LEI&rft.date=2015-12-01&rft.volume=12&rft.issue=6&rft.spage=8003&rft.epage=8009&rft.pages=8003-8009&rft.issn=1791-2997&rft.eissn=1791-3004&rft_id=info:doi/10.3892/mmr.2015.4427&rft_dat=%3Cgale_pubme%3EA439109692%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1932471166&rft_id=info:pmid/26461269&rft_galeid=A439109692&rfr_iscdi=true